Literature DB >> 4592901

Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.

O Y King, J R Wilbur, D M Mumford, W W Sutow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4592901     DOI： 10.1002/1097-0142(197403)33:3<611::aid-cncr2820330303>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors:  Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2011-12       Impact factor: 1.289

2.  Tumor inhibitory and non-tumor inhibitory L-asparaginases from Pseudomonas geniculata.

Authors:  G B Kitto; G Smith; T Q Thiet; M Mason; L Davidson
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

3.  Bacterial glutaminase in treatment of acute leukaemia.

Authors:  A S Spiers; H E Wade
Journal:  Br Med J       Date:  1976-05-29

4.  Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.

Authors:  Lynda M Vrooman; Jeffrey G Supko; Donna S Neuberg; Barbara L Asselin; Uma H Athale; Luis Clavell; Kara M Kelly; Caroline Laverdière; Bruno Michon; Marshall Schorin; Harvey J Cohen; Stephen E Sallan; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

5.  Acute parotitis during induction therapy including L-asparaginase in acute lymphoblastic leukemia.

Authors:  S Sica; L Pagano; P Salutari; A Di Mario; S Rutella; G Leone
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.